INTERVENTIONAL CARDIOLOGY: VASCULAR STENTS | GLOBAL MARKETS

120 Pages | 57 Exhibits | 2018 Analysis | Forecasts Through 2021 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for vascular stents.

INTERVENTIONAL CARDIOLOGY VASCULAR STENTS MARKET HIGHLIGHTS

  • The global market for vascular stents is steadily increasing in total sales due to a number of factors, including: the increasing prevalence of CVD, advances in CVD diagnostics, and a demand for minimally invasive interventional therapies to treat patients requiring surgical intervention to manage their conditions.
  • In 2016, the majority of total vascular stent sales were attributable to sales of DESs, which made up approximately 69% of total sales. BVSs are forecast to experience the strongest growth in terms of total unit sales throughout the forecast period.
  • The market for vascular stents is anticipated to experience CAGR of 6.2% during the forecast period (2016-21), reaching approximately $8.8bn in total product sales by 2021.
  • The market for vascular stents is anticipated to experience CAGR of 6.2% during the forecast period (2016-21), reaching approximately $8.8bn in total product sales by 2021.
  • Coronary stent sales accounted for approximately 71% of total vascular stent sales in 2016. The abundance of clinical data supporting the use of coronary stents has made stent implantation a primary interventional treatment option in treating coronary artery disease.
  • The US market for vascular stents accounted for approximately 36.1% of all sales, followed by the Rest of the World segment, which is growing rapidly due to demand for advanced therapies in emerging markets (eg China and India).
Topics Covered Include:
  • An overview of vascular stent products, including bare-metal stents (BMSs), drug-eluting stents (DESs), and bioresorbable vascular scaffolds (BVSs).
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Country and region-specific insights that are influencing the utilization of vascular stents.
  • Physician device preferences and utilization rates.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY 

i. Cardiovascular diseases overview 
ii. Global vascular stents market 
	a. Market drivers and limiters 
	b. Device segment insights
	c. Technology trends 
	d. Market leaders 
	e. Competitive strategies 
	f. Emerging competition 
iii. Methodology 

Exhibit ES-1: Vascular stents global market forecast, 2016-21 
Exhibit ES-2: Global vascular stents market, share by country/region, 2016 
Exhibit ES-3: Drivers and limiters of growth of the vascular stents market 

1. CARDIOVASCULAR DISEASES OVERVIEW
 
1.1 Acute coronary syndrome 
	1.1.1 Atherosclerosis 
	1.1.2 Angina pectoris 
	1.1.3 Myocardial infarction 
	1.1.4 Diagnosis and treatment
1.2 Hypertension 
1.3 Peripheral vascular disease 
	1.3.1 Critical limb ischemia 
	1.3.2 Aneurysm 
	1.3.3 Deep vein thrombosis/pulmonary embolism 
	1.3.4 Diagnosis and treatment
1.4 Cerebrovascular disease 
	1.4.1 Diagnosis and treatment
1.5 Bibliography 

Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries 
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select countries 
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions 
Exhibit 1-5: Clinical classification of acute myocardial infarction 
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions 
Exhibit 1-7: Estimated incident cases of myocardial infarction, select countries 
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries 
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries 
Exhibit 1-10: Estimated incident cases of DVT, select countries 
Exhibit 1-11: Estimated incident cases of PE, select countries 
Exhibit 1-12: Estimated incident cases of stroke, select countries 
Exhibit 1-13: Estimated prevalent cases of stroke, select countries 

2. VASCULAR STENT PRODUCTS
 
2.1 Vascular stent products 
2.2 Vascular stents in development 
2.3 Trends in vascular stent innovation 
2.4 Alternatives to vascular stent implantation 
2.5 Bibliography 

Exhibit 2-1: Advantages and disadvantages of stenting 
Exhibit 2-2: Images of select vascular stents 
Exhibit 2-3: Selected bare-metal stents and manufacturers 
Exhibit 2-4: Selected drug-eluting stents and manufacturers 
Exhibit 2-5: Advantages and disadvantages of BVSs 
Exhibit 2-6: Selected BVSs and manufacturers 
Exhibit 2-7: Current clinical trials investigating stent devices 
Exhibit 2-8: Selected drug-eluting BVSs in development
Exhibit 2-9: Information on selected non-drug-eluting BVSs in development 

3. VASCULAR STENTS MARKET
 
3.1 Global market insights 
	3.1.1 Market value 
	3.1.2 Technology trends 
	3.1.3 Market drivers and limiters 
	3.1.4 Vascular stents overview 
	3.1.5 Market leaders 
	3.1.6 Competitive strategies 
	3.1.7 Emerging competition 
3.2 Global competitors 
	3.2.1 Bare-metal stents 
	3.2.2 Drug-eluting stents 
3.3 Market forecast 
	3.3.1 Market forecast: US 
	3.3.2 Market forecast: five major EU markets 
	3.3.3 Market forecast: Japan 
	3.3.4 Market forecast: rest of the world 
3.4 Bibliography 

Exhibit 3-1: Vascular stents, global market forecast, 2016-21 
Exhibit 3-2: Vascular stent sales combined market forecast, by product segment ($m), 2016-21 
Exhibit 3-3: Global vascular stents market, share by country/region, 2016 
Exhibit 3-4: Global vascular stent sales combined market forecast, by country/region ($m), 2016-21 
Exhibit 3-5: Drivers and limiters of growth of the vascular stents market 
Exhibit 3-6: Average sale prices of vascular stents in 2017 
Exhibit 3-7: Global bare-metal stents market, share by supplier, 2016 
Exhibit 3-8: Global drug-eluting stents market, share by supplier, 2016 
Exhibit 3-9: US vascular stent implantation, procedure volumes forecast (000s), 2016-21 
Exhibit 3-10: US vascular stent sales combined market forecast, by product segment ($m), 2016-21 
Exhibit 3-11: US bare-metal stents market forecast, by type ($m), 2016-21
Exhibit 3-12: US bare-metal stents market, share by supplier, 2016 
Exhibit 3-13: US drug-eluting stents market forecast, by type ($m), 2016-21 
Exhibit 3-14: US drug-eluting stents market, share by supplier, 2016 
Exhibit 3-15: 5EU coronary vascular stent implantation, procedure volumes forecast, by country (000s), 2016-21 
Exhibit 3-16: 5EU peripheral vascular stent implantation, procedure volumes forecast, by country (000s), 2016-21 
Exhibit 3-17: 5EU vascular stent sales combined market forecast, by product segment ($m), 2016-21 
Exhibit 3-18: 5EU bare-metal stents market forecast, by type ($m), 2016-21 
Exhibit 3-19: 5EU bare-metal stents market, share by supplier, 2016 
Exhibit 3-20: 5EU drug-eluting stents market forecast, by type ($m), 2016-21 
Exhibit 3-21: 5EU drug-eluting stents market, share by supplier, 2016 
Exhibit 3-22: Japan vascular stent sales combined market forecast, by product segment ($m), 2016-21 
Exhibit 3-23: Japan coronary stent implantation, procedure volumes forecast (000s), 2016-21 
Exhibit 3-24: Japan bare-metal stents market forecast, by type ($m), 2016-21 
Exhibit 3-25: Japan bare-metal stents market, share by supplier, 2016 
Exhibit 3-26: Japan drug-eluting stents market forecast, by type ($m), 2016-21 
Exhibit 3-27: Japan drug-eluting stents market, share by supplier, 2016 
Exhibit 3-28: RoW vascular stent sales combined market forecast, by product segment ($m), 2016-21 
Exhibit 3-29: RoW bare-metal stents market forecast, by type ($m) 2016-21 
Exhibit 3-30: RoW bare-metal stents market, share by supplier, 2016 
Exhibit 3-31: RoW drug-eluting stents market forecast, by type ($m), 2016-21 
Exhibit 3-32: RoW drug-eluting stents market, share by supplier, 2016 

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. 480 Biomedical
  2. Abbott
  3. Alvimedica
  4. Amaranth Medical
  5. Arterial Remodeling Technologies
  6. Arterius
  7. B. Braun Medical/B. Braun Melsungen
  8. Balton
  9. Bentley
  10. BD
  11. Biosensors International
  12. BIOTRONIK
  13. Boston Scientific
  14. C.R. Bard/BD
  15. Cardinal Health
  16. Cardionovum
  17. CeloNova Biosciences
  18. CGBIO
  19. Comed
  20. Cook Medical/Cook Group
  21. Cordis/Cardinal Health
  22. Elixir Medical Corporation
  23. Envision Scientific
  24. eucatech
  25. Huaan Biotechnology
  26. Icon Interventional
  27. IMeSI Italia
  28. InSitu Technologies
  29. iVascular
  30. JOTEC
  31. JW Medical Systems
  32. Kyoto Medical Planning
  33. Lepu Medical
  34. Manli Cardiology
  35. Medinol
  36. Medtronic
  37. Meril Life Sciences
  38. Micell Technologies
  39. MicroPort Scientific
  40. Minvasys
  41. NATEC Medical
  42. NuMED
  43. OrbusNeich
  44. PQ Bypass
  45. REVA Medical
  46. Rontis
  47. S3V Vascular
  48. Sahajanand Medical Technologies
  49. Scitech
  50. Shandong Branden Med. Device Co.
  51. Shanghai Bio-heart Biological Technology
  52. Shockwave Medical
  53. STENTYS
  54. Svelte Medical Systems
  55. Terumo Interventional Systems
  56. Tryton Medical
  57. Vascular Concepts
  58. W.L. Gore
  59. Zorion Medical
  60. Zylox Medical Device Co.
Contact Us

Need help finding medtech research? Let us help you!